Nr2A (Grin2A) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
NR2A neurons express the NMDA receptor subunit NR2A (encoded by the GRIN2A gene), a critical ionotropic glutamate receptor involved in synaptic plasticity, learning, and memory. NMDA receptors containing the NR2A subunit exhibit distinct pharmacological and biophysical properties that are essential for normal brain function. [@nmda2020]
Structure and Molecular Biology
The NR2A subunit (also known as GluN2A or NMDA Receptor Subunit 2A) is a transmembrane protein that forms the NMDA receptor complex: [@developmental2018]
N-terminal domain (NTD): Large extracellular domain involved in subunit assembly and allosteric modulation
Agonist-binding domain (ABD): Binds glutamate (on NR2A) and glycine/D-serine (on NR1)
Transmembrane domain (TM): Three transmembrane helices plus a re-entrant pore loop
C-terminal domain (CTD): Long intracellular tail that interacts with scaffolding proteins and signaling molecules
Nr2A (Grin2A) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
NR2A neurons express the NMDA receptor subunit NR2A (encoded by the GRIN2A gene), a critical ionotropic glutamate receptor involved in synaptic plasticity, learning, and memory. NMDA receptors containing the NR2A subunit exhibit distinct pharmacological and biophysical properties that are essential for normal brain function. [@nmda2020]
Structure and Molecular Biology
The NR2A subunit (also known as GluN2A or NMDA Receptor Subunit 2A) is a transmembrane protein that forms the NMDA receptor complex: [@developmental2018]
N-terminal domain (NTD): Large extracellular domain involved in subunit assembly and allosteric modulation
Agonist-binding domain (ABD): Binds glutamate (on NR2A) and glycine/D-serine (on NR1)
Transmembrane domain (TM): Three transmembrane helices plus a re-entrant pore loop
C-terminal domain (CTD): Long intracellular tail that interacts with scaffolding proteins and signaling molecules
NMDA receptors are obligate heteromers typically composed of: [@grina2019]
Two NR1 subunits: The obligatory glycine/D-serine binding subunit
Two NR2 subunits (commonly NR2A or NR2B): The glutamate-binding subunit
Optionally NR3 subunits: Can modify receptor properties
NR2A-Specific Features
Fast deactivation kinetics: NR2A-containing receptors have faster decay times than NR2B-containing receptors
Higher open probability: More likely to conduct ions when activated
Rapastinel: NMDA receptor glycine site partial agonist
Animal Models
GRIN2A knockout mice: Viable but show learning and memory deficits
Conditional knockouts: Region-specific deletion
Transgenic NR2A overexpression: Enhanced LTP and memory
Humanized mice: Expressing human GRIN2A
Background
The study of Nr2A (Grin2A) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.